http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-078535-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46583b49082bd012bce6401fb6a842c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
filingDate 2010-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-078535-A1
titleOfInvention PIRROLO DERIVATIVES [2,3-B] PYRIDINE LIGANDOS OF STROGEN RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE OF THE SAME IN THE TREATMENT OF THE OSTEOPOROSIS AND DISEASES OF THE CENTRAL NERVOUS SYSTEM, AMONG OTHER
abstract Claim 1: A compound of the formula (1) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of said ester or amide, and a solvate of said ester, amide or salt, in which one of one of A, B, D and E represents nitrogen, and the other three of A, B, D and E represent CR3, CR4 and CR5; R1 is selected from the group consisting of hydrogen, halogen, cyano, nitro, ORA, N (RB) 2, -C (O) C1-4 alkyl, -SO2-C1-4 alkyl, C1-6 alkyl, C2-6 alkenyl C2-6 alkynyl, C1-6 haloalkyl, C1-6 dihaloalkyl, C1-6 trihaloalkyl, C2-6 haloalkenyl, C2-6 dihaloalkenyl, C2-6 trihaloalkenyl, C1-6 cyanoalkyl, C1-4alkoxy C1-6 alkyl, cycloalkyl C3-8, C3-8 cycloalkylC 1-6 alkyl, benzyl and 5-10 membered heterocyclyl, wherein said phenyl, benzyl or heterocyclyl group may be unsubstituted or substituted with 1 to 3 substituents, each of which is independently selected from the group consisting of ORA, halogen, cyano, nitro, -C (O) C1-4 alkyl, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 haloalkyl, C1-6 dihaloalkyl and C1- trihaloalkyl 6; R2 is selected from the group consisting of halogen, cyano, nitro, ORC, N (RB) 2, N (OH) 2, -CHO, -CH = N-OH, -C (O) C1-4 alkyl optionally substituted with 1 at 3 halogens, -SO2-C1-4 alkyl, -C (O) NH-OH, -C (NH2) N = OH, -C (CO2H) = N-OH, -C (NH2) = NH, -C (O-C1-4 alkyl) = NH, -C (NH2) = N-NH2, -NH-C (NH2) = NH, -NH-C (O) NH2, -N = C (-NH-CH2CH2- NH-), -S-CN, -SC (NH2) = NH, -SC (NH2) = N-OH, -CO2H, -CH2-CO2H, -CH (OH) CO2H, -C (O) N (RC ) 2, SO2N (RC) 2, -C (O) -C (O) -NH2, -CH2NH-CONH2, NHSO2RB, -C (O) CO2H, SO3H, CH2SO3H and 5-10 membered heterocyclyl wherein said heterocyclyl group it may be unsubstituted or substituted with 1 to 3 substituents, each of which is independently selected from the group consisting of ORA, halogen, cyano, nitro, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1 haloalkyl -6, C1-6 dihaloalkyl and C1-6 trihaloalkyl; each of R3, R4, R5, R6, R7, R8 and R9 is independently selected from the group consisting of hydrogen, ORA, halogen, cyano, nitro, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, haloalkyl C1-6, dihaloalkyl C1-6 and trihaloalkyl C1-6; each RA is independently selected from the group consisting of hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl C1-6 alkyl, phenyl, benzyl and heterocyclyl of 5 - 10 members, each of which is optionally substituted with 1 to 3 halogen atoms; each RB is independently selected from the group consisting of hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl, C 1-6 alkyl and 5-10 membered heterocyclyl, each of which is optionally substituted with 1 to 3 halogen atoms; and each RC is independently selected from the group consisting of hydrogen and C1-6 alkyl.
priorityDate 2009-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722

Total number of triples: 30.